Britannia Life Sciences Inc.
BLAB.CNCNQHealthcare● Active
$0.09
+$0.00(+0.00%)
Market Cap$13791619
P/E Ratio—
52W High$0.14
52W Low$0.06
Britannia Life Sciences Inc.（BLAB.CN）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BLAB.CN · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.37M | $7.57M | $6.40M | $7.30M | $1.42M |
| Cost of Revenue | $0.34M | $2.72M | $1.77M | $2.04M | $0.25M |
| Gross Profit | $0.03M | $4.85M | $4.64M | $5.26M | $1.17M |
| Gross Margin %(computed) | 7.40% | 64.12% | 72.43% | 72.08% | 82.24% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $1.99M | $3.24M | $3.40M | $13.43M | $0.75M |
| Total Operating Expenses | $2.28M | $4.68M | $4.46M | $4.88M | $1.06M |
| Operating Income | ($2.25M) | $0.17M | $0.18M | $0.38M | $0.11M |
| Operating Margin %(computed) | -609.28% | 2.29% | 2.78% | 5.20% | 8.06% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.11M | $1.28M | $0.85M | $2.31M | $0.36M |
| Income Before Tax | ($4.56M) | ($4.47M) | $5.86M | ($13.27M) | $0.40M |
| Income Tax Expense | $0.00M | ($0.07M) | $0.02M | $0.71M | $0.26M |
| Net Income | $7.39M | ($4.77M) | $5.08M | ($15.46M) | ($0.16M) |
| Net Margin %(computed) | — | -62.99% | 79.39% | -211.76% | -11.03% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.03 | $0.03 | $-0.14 | $-0.00 |
| Wtd Avg Shares | 162.25M | 162.25M | 162.14M | 109.50M | 76.75M |
| EBITDA | ($4.39M) | ($1.90M) | $6.95M | ($10.77M) | ($1.62M) |
| EBITDA Margin %(computed) | — | -25.05% | 108.61% | -147.55% | -113.54% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CAD · M
深入了解Britannia Life Sciences Inc.
关于Britannia Life Sciences Inc.（BLAB.CN）损益表
Britannia Life Sciences Inc.（BLAB.CN）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BLAB.CN实现营收$0.00B，毛利润$0.00B（毛利率7.40%），净利润$0.01B（净利率2001.95%）。
常见问题
BLAB.CN · 4 问Britannia Life Sciences Inc.（BLAB.CN）2025财年营收为$0.00B，同比down95.1%。
BLAB.CN revenueBLAB.CN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08